The health-data network that lets hospitals share medical insight without ever handing over the data - and an AI that reads it in the language of medicine.
In most of healthcare, the data already exists. The breakthroughs often don't - because the data can't move. Patient records sit inside hospitals, walled off by privacy law, incompatible formats, and the reasonable caution of institutions that hold some of the most sensitive information in the world. Briya, founded in 2020 by David Lazerson and Guy Tish, was built around an inversion of the usual approach: instead of trying to pool all that data in one place, keep it where it lives and share the insight instead.
That single design choice runs through everything the company does. Briya operates a secure, blockchain-secured exchange that standardizes electronic health records and lets hospitals, health systems, and academic institutions collaborate with life sciences organizations on anonymized, patient-level data - in compliance with HIPAA and GDPR, with the underlying records never leaving their source. On top of that network sits the company's flagship product, Briya AIRE, a clinical-grade AI research platform that lets scientists ask questions in plain language and get scientifically precise, epidemiologically valid answers back.
The scale has grown quickly. By April 2026, Briya's global network crossed 120 million patient records, spanning the United States, European Union, United Kingdom, Latin America, Asia, and the Middle East. For a company running with roughly 63 people across offices in New York, Nashville, and Tel Aviv, that is a lot of connective tissue - and it hints at where Briya wants to sit: not as another app, but as infrastructure underneath modern medical research.
We are firm believers in the granulation of data and adopting a data-driven approach tailored to the individual patient.
The problem Briya solves is a chicken-and-egg standoff: researchers need patient data to make progress, and institutions can't freely hand it over. Briya's architecture routes around it.
Records are standardized and stay at their source - no central warehouse, no copies.
A blockchain-secured exchange shares live, anonymized data in a HIPAA/GDPR-compliant way.
Scientists query the data in plain language and get validated, analysis-ready results.
Patient data sits fragmented across institutions and formats. Briya standardizes and connects it so researchers can actually use it - without the data leaving home.
Regulation makes sharing slow and risky. Briya's data-at-source, anonymized model is designed to be compliant with HIPAA and GDPR from the ground up.
AIRE turns work that took months of manual data wrangling into insights in minutes, lowering the cost of discovery for biopharma and academia alike.
A 120M-record network across four continents aims to give research the diverse, high-fidelity patient representation that personalized medicine requires.
The AI Research Environment - a clinical-grade conversational platform. Researchers ask questions in plain language, instantly translated into epidemiologically valid requests. Purpose-built AI agents handle literature review, hypothesis testing, population analysis, study design, data harmonization, and analytics, with collaboration tools, smart visualizations, and manuscript-ready outputs that carry built-in validation.
The blockchain-secured, decentralized backbone. It standardizes electronic health records and lets institutions share live, anonymized, patient-level data with life sciences organizations - keeping records at the source, compliant with HIPAA and GDPR.
Services for registry creation, patient-cohort identification, study validation, cross-dataset harmonization, and regulatory-compliant evidence generation - supporting clinical trials, endpoint validation, and drug discovery.
Approximate patient-record coverage as Briya expanded from a regional footprint to a global one.
Real-world data is a competitive market - names like TriNetX, Datavant, Truveta, Komodo Health, and Aetion all work in adjacent territory. Briya's distinction is architectural and conversational.
No central warehouse and no copies of raw records - a privacy posture many warehouse-based competitors don't share.
AIRE lets clinicians and even students run rigorous analysis without a data-science team standing between them and the answer.
Built to “think” in medicine, epidemiology, and clinical research - reinforced by hiring a Chief Epidemiologist to keep the science honest.
We are actively engaged in establishing strategic cooperations and partnerships with healthcare providers and life science companies globally.
Briya links the institutions that hold patient data - hospitals, health systems, academic centers - to the biopharma and life-science organizations that need real-world data and evidence. It monetizes secure, compliant access to the network and the AIRE platform, while offering free tiers to academics and the scientific community to widen adoption.
Emerging biotechs, life sciences organizations, academic institutions, health systems, epidemiologists, and clinical researchers - down to individual student researchers. The through-line: anyone who needs rigorous answers from real-world medical data, fast.
Led by Team8 to accelerate the US rollout of Briya's data exchange platform.
Across rounds, with backing that also includes Innocare Health Investments. Scientific advisors include Dr. Fabio Lievano (AbbVie) and Moshe Bar Siman-Tov (former DG, Israeli Ministry of Health).
David Lazerson and Guy Tish start Briya with a cryptography-based idea for making health data shareable, secure, and compliant.
Team8 leads an $11.5M round with Insight Partners and Amiti Ventures, bringing total funding to $17M and funding the US rollout.
The company unveils AIRE, a clinical-grade conversational AI platform for biomedical and epidemiological research.
The network passes 120 million patient records, Briya appoints a Chief Epidemiologist, and opens free AIRE access to the global scientific community.
Briya opens no-cost access to AIRE for the global scientific community, positioning it as a transparent AI research platform.
Professor Jonathan Samet, MD, MS joins to reinforce academic rigor in AI-driven clinical research.
The network crosses 120 million patient records, expanding into Latin America and the UK.
Briya introduces its clinical-grade conversational AI research platform.
Briya operates a secure, privacy-preserving healthcare data exchange network and a clinical-grade AI research platform (AIRE) that connect hospitals and researchers with life sciences organizations to accelerate medical research.
AIRE (AI Research Environment) is Briya's conversational AI platform that lets researchers query and analyze real-world medical data in plain language, with purpose-built agents for study design, hypothesis testing, and analytics.
Briya was founded in 2020 by David Lazerson (CEO) and Guy Tish (CTO).
Briya has raised $17M in total, including an $11.5M Series A in September 2023 led by Team8 with Insight Partners and Amiti Ventures.
Briya keeps data at its source rather than in central warehouses, uses a blockchain-secured exchange to share anonymized data, and operates in compliance with HIPAA and GDPR.